Do migraine patients have higher levels of misophonia compared to healthy controls?


Şahin A., Çakır S., Aydınlar E., Ertaş M., Yalınay Dikmen P.

21st International Headache Congress, Seoul, Güney Kore, 14 - 17 Eylül 2023, ss.114

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Seoul
  • Basıldığı Ülke: Güney Kore
  • Sayfa Sayıları: ss.114
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Objective: Misophonia is characterized by a negative emotional response, such as anxiety, irritability, or restlessness, towards certain sounds, including but not limited to tapping, chewing, typing, breathing, swallowing, or foot tapping. Phonophobia is a subtype of misophonia characterized by fear as the dominant emotion. However, misophonia is characterized by other dominant emotions, such as irritation, stress and anxiety, aggravation, feeling trapped, and impatience. Migraine is often associated with other neurological and psychiatric disorders such as depression, and anxiety. These comorbid conditions can significantly impact the frequency, severity, and duration of migraine attacks, as well as the response to treatment. Phonophobia may be related to both ictal and interictal phases of migraine. However, misophonia has not been studied in migraine yet. The aim of this study was to investigate whether misophonia is more prevalent in patients with migraine compared to healthy individuals. Additionally, we aimed to explore the association between misophonia and migraine-related disability, depression, anxiety, stress levels, and obsessive-compulsive traits. Methods: We recruited 205 patients with migraine as a migraine group (MG) and 205 healthy subjects as a control group (CG). Demographics, Headache Impact Test-6 (HIT-6), Depression Anxiety Stress Scale (DASS-21), Misophonia Scale (total score and severity scale), Yale Brown Obsessive Compulsive Scale (Y-BOCS) were recorded from all participants. In the MG, clinical features of migraine, Migraine Disability Assessment Test (MIDAS) and Allodynia Symptom Checklist were also obtained. Results: The mean age [36.5 (9.5) vs. 36.5 (10.1); p ¼ 0.956] and gender distributions were similar between the MG and the CG. In the MG, the mean duration of migraine was 14.1 years and the mean number of headache days in the last month was 8.6 (6.7) days. The mean MIDAS score was found to be 19.1 (21.5). In the MG, 22.4% of the patients had chronic migraine. The percentage of patients exceeding the Misophonia Severity Scale cut-off level (3 7) was found to be higher in the MG than the CG (44.9% vs. 17.6%, p < 0.001). The MG showed higher levels of interictal photophobia (53.7% vs. 37.6%, p < 0.001), interictal phonophobia (67.3% vs. 36.6%, p < 0.001), and interictal osmophobia (49.8% vs. 41.0%, p > 0.001) compared to the CG. The MG also showed statistical difference in the HIT-6 scores [65.2 (6.4) vs. 42.9 (6); p > 0.001], the mean depression scores of DASS-21 [5.2 (4.7) vs. 3.93(3.5); p > 0.001], the mean anxiety scores of DASS-21 [4.6 (3.9) vs. 2.9 (2.8); p > 0.001], the mean stress scores of DASS-21 [7.8 (4.4) vs. 5.4 (3.5); p > 0.001], the Misophonia Scale total scores [34.7 (15.1) vs. 21.4 (13.7); p > 0.001] and the Misophonia Scale severity scores [6.7 (3.2) vs. 4.1 (2.5); p > 0.001] compared to the CG. No difference was observed in the mean Y114 Cephalalgia 43(1S) ! International Headache Society 2023 BOCS scores [11.3 (9.0) vs. 9.4 (8.3); p ¼ 0.317] between the two groups. Conclusion: In our cohort, misophonia was more common in migraine patients compared to healthy controls. Besides, misophonia showed a positive correlation to the duration of migraine, depression, anxiety, stress levels and obsessive-compulsive traits in the MG. Therefore, it is recommended to consider misophonia when evaluating comorbidity in migraine patients. Future studies will reveal the relationship between migraine and misophonia and its effect on the course of migraine.